Clinical Trial Update: Study of Efficacy and Safety of Osilodrostat in Cushing's Syndrome [Phase 2]

View source ↗

Summary

Phase 2 trial update on osilodrostat for Cushing's syndrome, reporting efficacy and safety results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cushing Syndrome

Drugs mentioned

• Osilodrostat (osilodrostat)

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Cushing's Syndrome, Ectopic Corticotropin Syndrome | Phase 2 | Status: COMPLETED | Results posted: 2020-03-11